Synthesis and anti-angiogenic activity of benzothiazole, benzimidazole containing phthalimide derivatives

被引：24

作者：

Nagarajan, Shunmugam ^{[1
]}

Majumder, Syamantak ^{[1
]}

Sharma, Upendra ^{[2
]}

Rajendran, Saranya ^{[1
]}

Kumar, Neeraj ^{[2
]}

Chatterjee, Suvro ^{[1
]}

Singh, Bikram ^{[2
]}

机构：

[1] Anna Univ, AU KBC Res Ctr, Vasc Biol Lab, Madras 600044, Tamil Nadu, India

[2] CSIR Inst Himalayan Bioresource Technol, Nat Plant Prod Div, Palampur 176061, Himachal Prades, India

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2013年 / 23卷 / 01期

关键词：

Thalidomide; Anti-angiogenesis; Phthalimide; ANTITUMOR BENZOTHIAZOLES; THALIDOMIDE; MIGRATION; ANALOGS;

D O I：

10.1016/j.bmcl.2012.10.106

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Benzothiazole and benzimidazole containing phthalimide derivatives (NK037, NK041, NK042, NK0139A and NK0148) have been synthesized and their anti-angiogenic activity was evaluated using ex vivo egg yolk angiogenesis model. A comparative study with pure thalidomide (NKTA) has also been performed to describe the efficacy of these derivatives in blocking angiogenesis. NK037, NK041 and NK042 were equally potent in blocking egg yolk angiogenesis and the anti-angiogenesis effect was higher than NKTA suggesting the efficacy of these three derivatives in blocking angiogenesis when compare to control. Other two derivatives NK0139A and NK0148 showed effect less than NKTA and stronger than control in ex vivo angiogenesis. (c) 2012 Published by Elsevier Ltd.

引用

页码：287 / 290

页数：4

共 28 条

[1] Facile Synthesis and In-Vitro Antitumor Activity of Some Pyrazolo[3,4-b]pyridines and Pyrazolo[1,5-a]pyrimidines Linked to a Thiazolo[3,2-a]benzimidazole Moiety [J].

Abdel-Aziz, Hatem A. ;

Saleh, Tamer S. ;

El-Zahabi, Heba S. A. .

ARCHIV DER PHARMAZIE, 2010, 343 (01) :24-30

[2]

Alper Sabiha, 2003, Farmaco (Lausanne), V58, P497, DOI 10.1016/S0014-827X(03)00042-9

[3] Timeline - The evolution of thalidomide and its IMiD derivatives as anticancer agents [J].

Bartlett, JB ;

Dredge, K ;

Dalgleish, AG .

NATURE REVIEWS CANCER, 2004, 4 (04) :314-322

[4] Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases [J].

Bodolay, E ;

Koch, AE ;

Kim, J ;

Szegedi, G ;

Szekanecz, Z .

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2002, 6 (03) :357-376

[5] Thalidomide: Current and potential clinical applications [J].

Calabrese, L ;

Fleischer, AB .

AMERICAN JOURNAL OF MEDICINE, 2000, 108 (06) :487-495

[6] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J].

DAMATO, RJ ;

LOUGHNAN, MS ;

FLYNN, E ;

FOLKMAN, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4082-4085

[7] Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro [J].

Dredge, K ;

Horsfall, R ;

Robinson, SP ;

Zhang, LH ;

Lu, L ;

Tang, Y ;

Shirley, MA ;

Muller, G ;

Schafer, P ;

Stirling, D ;

Dalgleish, AG ;

Bartlett, JB .

MICROVASCULAR RESEARCH, 2005, 69 (1-2) :56-63

[8] Anti-angiogenesis as a therapeutic strategy for cancer [J].

Fantl, WJ ;

Rosenberg, S .

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35, 2000, 35 :123-133

[9] Structural development of biological response modifiers based on thalidomide [J].

Hashimoto, Y .

BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (03) :461-479

[10] Antitumour benzothiazoles.: Part 20:: 3′-cyano and 3′-alkynyl-substituted 2-(4′-aminophenyl)benzothiazoles as new potent and selective analogues [J].

Hutchinson, I ;

Bradshaw, TD ;

Matthews, CS ;

Stevens, MFG ;

Westwell, AD .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) :471-474

← 1 2 3 →